131 related articles for article (PubMed ID: 12455466)
1. Wet film dimensions of capsule walls during dip coating.
Keary CM; Heeschen WA
Drug Dev Ind Pharm; 2002 Oct; 28(9):1059-76. PubMed ID: 12455466
[TBL] [Abstract][Full Text] [Related]
2. The in vitro dissolution of theophylline from different types of hard shell capsules.
Podczeck F; Jones BE
Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
[TBL] [Abstract][Full Text] [Related]
3. HPMC capsules: current status and future prospects.
Al-Tabakha MM
J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
[TBL] [Abstract][Full Text] [Related]
4. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
5. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
Kuentz M; Rothenhäusler B; Röthlisberger D
Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the film-coating properties of a hydroxyethyl cellulose/hydroxypropyl methylcellulose polymer system.
Li SP; Martellucci SA; Bruce RD; Kinyon AC; Hay MB; Higgins JD
Drug Dev Ind Pharm; 2002 Apr; 28(4):389-401. PubMed ID: 12056532
[TBL] [Abstract][Full Text] [Related]
7. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
El-Malah Y; Nazzal S; Bottom CB
Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
[TBL] [Abstract][Full Text] [Related]
8. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
9. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
10. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
Ku MS; Lu Q; Li W; Chen Y
Int J Pharm; 2011 Sep; 416(1):16-24. PubMed ID: 21356291
[TBL] [Abstract][Full Text] [Related]
11. Performance of multilayered particles: influence of a thin cushioning layer.
Chambin O; Rota A; Rochat-Gonthier MH; Pourcelot Y
Drug Dev Ind Pharm; 2005 Sep; 31(8):739-46. PubMed ID: 16221608
[TBL] [Abstract][Full Text] [Related]
12. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
Birchall JC; Jones BE; Morrissey A; Jones BE
Drug Dev Ind Pharm; 2008 Aug; 34(8):870-6. PubMed ID: 18686093
[TBL] [Abstract][Full Text] [Related]
14. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets.
Siepmann J; Podual K; Sriwongjanya M; Peppas NA; Bodmeier R
J Pharm Sci; 1999 Jan; 88(1):65-72. PubMed ID: 9874704
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
Ishida M; Abe K; Hashizume M; Kawamura M
Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
[TBL] [Abstract][Full Text] [Related]
16. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients.
Wikström H; Carroll WJ; Taylor LS
Pharm Res; 2008 Apr; 25(4):923-35. PubMed ID: 17896097
[TBL] [Abstract][Full Text] [Related]
17. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
[TBL] [Abstract][Full Text] [Related]
18. Effect of formulation conditions on hypromellose performance properties in films used for capsules and tablet coatings.
Curtis-Fisk J; Sheskey P; Balwinski K; Coppens K; Mohler C; Zhao J
AAPS PharmSciTech; 2012 Dec; 13(4):1170-8. PubMed ID: 22961412
[TBL] [Abstract][Full Text] [Related]
19. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
Levina M; Rajabi-Siahboomi AR
J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
[TBL] [Abstract][Full Text] [Related]
20. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 1: materials used to formulate microcapsules.
Rogers TL; Wallick D
Drug Dev Ind Pharm; 2012 Feb; 38(2):129-57. PubMed ID: 21913871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
